Research Article| Volume 312, ISSUE 1-2, P52-56, January 15, 2012

Download started.


Morvan's syndrome associated with antibodies to multiple components of the voltage-gated potassium channel complex

Published:September 09, 2011DOI:


      We describe a patient presenting with a combination of muscle fasciculations, paresthesias, hyperhidrosis, as well as insomnia, agitation and confusion. He went on to develop psychosis and respiratory failure requiring intensive care. Electromyography confirmed the presence of neuromyotonia and CSF showed mild pleocytosis. Routine testing for voltage-gated potassium channel complex (VGKC-complex) antibodies was highly positive, confirming the clinical diagnosis of Morvan's syndrome. The patient improved after treatment with intravenous immunoglobulin and methylprednisolone. Further investigation of the antigenic targets using immunohistochemistry and cell-based assays revealed that he had autoantibodies targeting Lgi1, Caspr2 and Contactin-2/Tag-1, all proteins known to be complexed with VGKC in peripheral nerves and CNS. This is the first case of Morvan's syndrome from Cyprus and illustrates the clinical features as well as the emerging complexity of antigenic targets involved in the pathogenesis.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Newsom-Davis J.
        • Mills K.R.
        Immunological associations of acquired neuromyotonia (Isaacs syndrome) — report of five cases and literature review.
        Brain. 1993; 116: 453-469
        • Hart I.
        • Maddison P.
        • Newsom-Davis J.
        • Vincent A.
        • Mills K.
        Phenotypic variants of autoimmune peripheral nerve hyperexcitability.
        Brain. 2002; 125: 1887-1895
        • Barber P.A.
        • Anderson N.E.
        • Vincent A.
        Morvan's syndrome associated with voltage-gated K+ channel antibodies.
        Neurology. 2000; 54: 771-772
        • Liguori R.
        • Vincent A.
        • Clover L.
        • Avoni P.
        • Plazzi G.
        • Cortelli P.
        • et al.
        Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels.
        Brain. 2001; 124: 2417-2426
        • Rinaldi C.
        • Russo C.V.
        • Filla A.
        • De Michele G.
        • Marano E.
        Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome.
        Neurol Sci. 2009; 30: 237-239
        • Löscher W.N.
        • Wanschitz J.
        • Reiners K.
        • Quasthoff S.
        Morvan's syndrome: clinical, laboratory, and in vitro electrophysiological studies.
        Muscle Nerve. 2004; 30: 157-163
        • Irani S.R.
        • Alexander S.
        • Waters P.
        • Kleopa K.A.
        • Pettingill P.
        • Zuliani L.
        • et al.
        Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.
        Brain. 2010; 133: 2734-2748
        • Kleopa K.A.
        • Elman L.
        • Lang B.
        • Vincent A.
        • Scherer S.S.
        Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations.
        Brain. 2006; 129: 1570-1584
        • Vincent A.
        Autoimmune channelopathies: well-established and emerging immunotherapy-responsive diseases of the peripheral and central nervous systems.
        J Clin Immunol. 2010; : S97-S102
        • Bajaj B.K.
        • Shrestha S.
        An interesting case report of Morvan's syndrome from the Indian subcontinent.
        Neurol India. 2007; 55: 67-69
        • Lee E.
        • Maselli R.
        • Ellis W.
        • Agius M.
        Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma.
        J Neurol Neurosurg Psychiatry. 1998; 65: 857-862
        • Madrid A.
        • Gil-Peralta A.
        • Gil-Néciga E.
        • González J.R.
        • Jarrín S.
        Morvan's fibrillary chorea: remission after plasmapheresis.
        J Neurol. 1996; 243: 350-353
        • Halbach M.
        • Homberg V.
        • Freund H.J.
        Neuromuscular, autonomic and central cholinergic hyperactivity associated with thymoma and acetylcholine receptor-binding antibody.
        J Neurol. 1987; 234: 433-436
        • Josephs K.A.
        • Silber M.H.
        • Fealey R.D.
        • Nippoldt T.B.
        • Auger R.G.
        • Vernino S.
        Neurophysiologic studies in Morvan syndrome.
        J Clin Neurophysiol. 2004; 21: 440-445
        • Díaz-Manera J.
        • Rojas-García R.
        • Gallardo E.
        • Juárez C.
        • Martínez-Domeño A.
        • Martínez-Ramírez S.
        • et al.
        Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
        Nat Clin Pract Neurol. 2007; 3: 405-410
        • Cornelius J.R.
        • Pittock S.J.
        • McKeon A.
        • Lennon V.A.
        • Aston P.A.
        • Josephs K.A.
        • et al.
        Sleep manifestations of voltage-gated potassium channel complex autoimmunity.
        Arch Neurol. 2011; 68: 733-738
        • Geschwind M.D.
        • Tan K.M.
        • Lennon V.A.
        • Barajas Jr., R.F.
        Haman A, Klein CJ and others. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt–Jakob disease.
        Arch Neurol. 2008; 65: 1341-1346
        • Poliak S.
        • Gollan L.
        • Martinez R.
        • Custer A.
        • Einheber S.
        • Salzer J.L.
        • et al.
        Caspr2, a new member of the neurexin superfamily is localized at the juxtaparanodes of myelinated axons and associates with K+ channels.
        Neuron. 1999; 24: 1037-1047
        • Traka M.
        • Goutebroze L.
        • Denisenko N.
        • Bessa M.
        • Nifli A.
        • Havaki S.
        • et al.
        Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers.
        J Cell Biol. 2003; 162: 1161-1172
        • Poliak S.
        • Salomon D.
        • Elhanany H.
        • Sabanay H.
        • Kiernan B.
        • Pevny L.
        • et al.
        Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1.
        J Cell Biol. 2003; 162: 1149-1160